Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Digitas Health

    - PMLiVE

    Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership

    The collaboration will see Boehringer use an IBM-developed AI model to boost its drug discovery efforts

    - PMLiVE

    Researchers improve understanding of COVID-19 virus and future variants

    The study aims to contribute to the design of future COVID-19 vaccines and drugs

    - PMLiVE

    Moderna and IBM to explore quantum computing and AI for future mRNA medicines

    A growing number of biopharmas have been investing in quantum computing over recent years

    - PMLiVE

    Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease

    Researchers identified eight Parkinson’s disease states, with seven outcomes associated with terminal Parkinson’s disease

    Leveraging Data, Technology & Expertise to Solve Problems & Transform Healthcare

    Tushar Pant, Consulting Executive in Healthcare at IBM, discusses how technology is transforming healthcare. Among many other things, we explore how IBM is working to improve the healthcare industry in Canada,...

    Impetus Digital

    - PMLiVE

    Key emerging trends in digital health

    Improving healthcare for patients and helping doctors be more efficient

    - PMLiVE

    Current and future trends for developing digital medical communications

    Evolving digital trends and user needs

    - PMLiVE

    BMS partners with Voluntis to co-develop oncology digital therapeutics

    Aims to create a mobile app to help patients self-manage their symptoms

    Digital divergence

    Combining digital and pharma is proving less easy than previously thought

    - PMLiVE

    A snapshot of Congenica

    PME talks to CEO David Atkins

    - PMLiVE

    The digital shift in pharma marketing

    Indegene’s surveys in 2016 and 2019 show a spike in digital spend

    - PMLiVE

    Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte

    Alexander Davies considers the remarkable story of how one company broke with pharma convention to speak out on social media

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links